Xenon Pharmaceuticals Inc. <XENE.O>: Wedbush cuts target price to $55 from $71
XENE•Related News
BlossomHill net loss widens 79.35% to $23.8 million in Q2 FY26; R&D expenses rise 70.78% to $21.4 million
BLSM•
Ultragenyx rises after FDA nod for rare disorder drug
RARE•
Magna International Inc. <MGA.N>: BMO cuts to market perform from outperform; cuts target price to $70 from $76
MGA•
Philip Morris raises quarterly dividend 8.8% to USD 1.6 a share
PM•
SL Green declares quarterly common dividend of $0.62 a share
SLG•